Global Human Insulin Market with Size, Status and Forecast 2025


Report ID : RNR-217476 Category : Pharma Healthcare Published Date : 2018
Publisher : QYResearch Pages : 102 Format : PDF
The Global Human Insulin Market Research Report is a valuable source of insightful data for business strategists. It provides the Human Insulin industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Human Insulin market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

In this report, the global Human Insulin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Insulin in these regions, from 2013 to 2025 (forecast), covering

    North America

    Europe

    China

    Japan

    Southeast Asia

    India

Global Human Insulin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

    Sanofi (France)

    Eli Lilly and Company (U.S.)

    Biocon Ltd. (India)

    Julphar (U.A.E.)

    Ypsomed AG (Switzerland)

    Becton

    Dickinson and Company (U.S.)

    Wockhardt Ltd. (India)

    B. Braun Meselgen AG (Switzerland)

    Biodel Inc(U.S.)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

    Short Acting Human Insulin

    Intermediate Acting Human Insulin

    Premixed Human Insulin

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

    Insulin Dependent Diabetes Mellitus

    Non-Insulin Dependent Diabetes Mellitus

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Human Insulin Market with Size, Status and Forecast 2025

1 Human Insulin Market Overview

    1.1 Product Overview and Scope of Human Insulin

    1.2 Human Insulin Segment by Type (Product Category)

        1.2.1 Global Human Insulin Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)

        1.2.2 Global Human Insulin Production Market Share by Type (Product Category) in 2017

        1.2.3 Short Acting Human Insulin

        1.2.4 Intermediate Acting Human Insulin

        1.2.5 Premixed Human Insulin

    1.3 Global Human Insulin Segment by Application

        1.3.1 Human Insulin Consumption (Sales) Comparison by Application (2013-2025)

        1.3.2 Insulin Dependent Diabetes Mellitus

        1.3.3 Non-Insulin Dependent Diabetes Mellitus

    1.4 Global Human Insulin Market by Region (2013-2025)

        1.4.1 Global Human Insulin Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)

        1.4.2 North America Status and Prospect (2013-2025)

        1.4.3 Europe Status and Prospect (2013-2025)

        1.4.4 China Status and Prospect (2013-2025)

        1.4.5 Japan Status and Prospect (2013-2025)

        1.4.6 Southeast Asia Status and Prospect (2013-2025)

        1.4.7 India Status and Prospect (2013-2025)

    1.5 Global Market Size (Value) of Human Insulin (2013-2025)

        1.5.1 Global Human Insulin Revenue Status and Outlook (2013-2025)

        1.5.2 Global Human Insulin Capacity, Production Status and Outlook (2013-2025)

2 Global Human Insulin Market Competition by Manufacturers

    2.1 Global Human Insulin Capacity, Production and Share by Manufacturers (2013-2018)

        2.1.1 Global Human Insulin Capacity and Share by Manufacturers (2013-2018)

        2.1.2 Global Human Insulin Production and Share by Manufacturers (2013-2018)

    2.2 Global Human Insulin Revenue and Share by Manufacturers (2013-2018)

    2.3 Global Human Insulin Average Price by Manufacturers (2013-2018)

    2.4 Manufacturers Human Insulin Manufacturing Base Distribution, Sales Area and Product Type

    2.5 Human Insulin Market Competitive Situation and Trends

        2.5.1 Human Insulin Market Concentration Rate

        2.5.2 Human Insulin Market Share of Top 3 and Top 5 Manufacturers

        2.5.3 Mergers & Acquisitions, Expansion

3 Global Human Insulin Capacity, Production, Revenue (Value) by Region (2013-2018)

    3.1 Global Human Insulin Capacity and Market Share by Region (2013-2018)

    3.2 Global Human Insulin Production and Market Share by Region (2013-2018)

    3.3 Global Human Insulin Revenue (Value) and Market Share by Region (2013-2018)

    3.4 Global Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

    3.5 North America Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

    3.6 Europe Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

    3.7 China Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

    3.8 Japan Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

    3.9 Southeast Asia Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

    3.10 India Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Human Insulin Supply (Production), Consumption, Export, Import by Region (2013-2018)

    4.1 Global Human Insulin Consumption by Region (2013-2018)

    4.2 North America Human Insulin Production, Consumption, Export, Import (2013-2018)

    4.3 Europe Human Insulin Production, Consumption, Export, Import (2013-2018)

    4.4 China Human Insulin Production, Consumption, Export, Import (2013-2018)

    4.5 Japan Human Insulin Production, Consumption, Export, Import (2013-2018)

    4.6 Southeast Asia Human Insulin Production, Consumption, Export, Import (2013-2018)

    4.7 India Human Insulin Production, Consumption, Export, Import (2013-2018)

5 Global Human Insulin Production, Revenue (Value), Price Trend by Type

    5.1 Global Human Insulin Production and Market Share by Type (2013-2018)

    5.2 Global Human Insulin Revenue and Market Share by Type (2013-2018)

    5.3 Global Human Insulin Price by Type (2013-2018)

    5.4 Global Human Insulin Production Growth by Type (2013-2018)

6 Global Human Insulin Market Analysis by Application

    6.1 Global Human Insulin Consumption and Market Share by Application (2013-2018)

    6.2 Global Human Insulin Consumption Growth Rate by Application (2013-2018)

    6.3 Market Drivers and Opportunities

        6.3.1 Potential Applications

        6.3.2 Emerging Markets/Countries

7 Global Human Insulin Manufacturers Profiles/Analysis

    7.1 Sanofi (France)

        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.1.2 Human Insulin Product Category, Application and Specification

            7.1.2.1 Product A

            7.1.2.2 Product B

        7.1.3 Sanofi (France) Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.1.4 Main Business/Business Overview

    7.2 Eli Lilly and Company (U.S.)

        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.2.2 Human Insulin Product Category, Application and Specification

            7.2.2.1 Product A

            7.2.2.2 Product B

        7.2.3 Eli Lilly and Company (U.S.) Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.2.4 Main Business/Business Overview

    7.3 Biocon Ltd. (India)

        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.3.2 Human Insulin Product Category, Application and Specification

            7.3.2.1 Product A

            7.3.2.2 Product B

        7.3.3 Biocon Ltd. (India) Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.3.4 Main Business/Business Overview

    7.4 Julphar (U.A.E.)

        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.4.2 Human Insulin Product Category, Application and Specification

            7.4.2.1 Product A

            7.4.2.2 Product B

        7.4.3 Julphar (U.A.E.) Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.4.4 Main Business/Business Overview

    7.5 Ypsomed AG (Switzerland)

        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.5.2 Human Insulin Product Category, Application and Specification

            7.5.2.1 Product A

            7.5.2.2 Product B

        7.5.3 Ypsomed AG (Switzerland) Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.5.4 Main Business/Business Overview

    7.6 Becton

        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.6.2 Human Insulin Product Category, Application and Specification

            7.6.2.1 Product A

            7.6.2.2 Product B

        7.6.3 Becton Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.6.4 Main Business/Business Overview

    7.7 Dickinson and Company (U.S.)

        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.7.2 Human Insulin Product Category, Application and Specification

            7.7.2.1 Product A

            7.7.2.2 Product B

        7.7.3 Dickinson and Company (U.S.) Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.7.4 Main Business/Business Overview

    7.8 Wockhardt Ltd. (India)

        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.8.2 Human Insulin Product Category, Application and Specification

            7.8.2.1 Product A

            7.8.2.2 Product B

        7.8.3 Wockhardt Ltd. (India) Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.8.4 Main Business/Business Overview

    7.9 B. Braun Meselgen AG (Switzerland)

        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.9.2 Human Insulin Product Category, Application and Specification

            7.9.2.1 Product A

            7.9.2.2 Product B

        7.9.3 B. Braun Meselgen AG (Switzerland) Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.9.4 Main Business/Business Overview

    7.10 Biodel Inc(U.S.)

        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

        7.10.2 Human Insulin Product Category, Application and Specification

            7.10.2.1 Product A

            7.10.2.2 Product B

        7.10.3 Biodel Inc(U.S.) Human Insulin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

        7.10.4 Main Business/Business Overview

8 Human Insulin Manufacturing Cost Analysis

    8.1 Human Insulin Key Raw Materials Analysis

       8.1.1 Key Raw Materials

       8.1.2 Price Trend of Key Raw Materials

       8.1.3 Key Suppliers of Raw Materials

       8.1.4 Market Concentration Rate of Raw Materials

    8.2 Proportion of Manufacturing Cost Structure

       8.2.1 Raw Materials

       8.2.2 Labor Cost

       8.2.3 Manufacturing Expenses

    8.3 Manufacturing Process Analysis of Human Insulin

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

    9.1 Human Insulin Industrial Chain Analysis

    9.2 Upstream Raw Materials Sourcing

    9.3 Raw Materials Sources of Human Insulin Major Manufacturers in 2017

    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

    10.1 Marketing Channel

        10.1.1 Direct Marketing

        10.1.2 Indirect Marketing

        10.1.3 Marketing Channel Development Trend

    10.2 Market Positioning

        10.2.1 Pricing Strategy

        10.2.2 Brand Strategy

        10.2.3 Target Client

    10.3 Distributors/Traders List

11 Market Effect Factors Analysis

    11.1 Technology Progress/Risk

        11.1.1 Substitutes Threat

        11.1.2 Technology Progress in Related Industry

    11.2 Consumer Needs/Customer Preference Change

    11.3 Economic/Political Environmental Change

12 Global Human Insulin Market Forecast (2018-2025)

    12.1 Global Human Insulin Capacity, Production, Revenue Forecast (2018-2025)

        12.1.1 Global Human Insulin Capacity, Production and Growth Rate Forecast (2018-2025)

        12.1.2 Global Human Insulin Revenue and Growth Rate Forecast (2018-2025)

        12.1.3 Global Human Insulin Price and Trend Forecast (2018-2025)

    12.2 Global Human Insulin Production, Consumption , Import and Export Forecast by Region (2018-2025)

        12.2.1 North America Human Insulin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

        12.2.2 Europe Human Insulin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

        12.2.3 China Human Insulin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

        12.2.4 Japan Human Insulin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

        12.2.5 Southeast Asia Human Insulin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

        12.2.6 India Human Insulin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

    12.3 Global Human Insulin Production, Revenue and Price Forecast by Type (2018-2025)

    12.4 Global Human Insulin Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix

    14.1 Methodology/Research Approach

        14.1.1 Research Programs/Design

        14.1.2 Market Size Estimation

        14.1.3 Market Breakdown and Data Triangulation

    14.2 Data Source

        14.2.1 Secondary Sources

        14.2.2 Primary Sources

    14.3 Disclaimer